Semaglutide vs Ozempic: What Is the Difference and Which One Is Right for You?

If you have been paying attention to the weight loss conversation over the past two years, you have heard of Ozempic. It is everywhere — celebrity rumors, news headlines, social media. But there is a lot of confusion about what it actually is, how it works, and whether compounded semaglutide is a safe and effective alternative. Let us break it down.

What Is Semaglutide?

Semaglutide is the active drug — a GLP-1 receptor agonist that mimics a hormone your gut naturally produces when you eat. It works by telling your brain you are full, slowing digestion, and significantly reducing cravings for high-fat and high-sugar foods. The result is that most people naturally eat much less without feeling deprived, and weight comes off steadily over time.

So What Is Ozempic?

Ozempic is a brand name for semaglutide — specifically the version manufactured by Novo Nordisk and FDA-approved for type 2 diabetes management. Wegovy is the same drug at a higher dose, approved specifically for weight loss. Both are name-brand, injectable semaglutide products.

What Is Compounded Semaglutide?

Compounded semaglutide is semaglutide prepared by a licensed compounding pharmacy — the same active ingredient, customized to the patient. It became widely available during the Ozempic shortage that began in 2022 and has remained popular because it is significantly more affordable than the brand-name versions, which can cost $1,000 or more per month without insurance.

At MedTech Management, we work with licensed compounding pharmacies to provide medically supervised semaglutide programs at a fraction of the brand-name cost.

Is Compounded Semaglutide Safe?

When sourced from a licensed, accredited compounding pharmacy and prescribed by a qualified medical provider, compounded semaglutide is considered safe and effective. The key is medical supervision — proper dosing, monitoring, and a protocol tailored to your body and goals. This is not something you should order from an unregulated online source.

Who Is a Good Candidate?

Semaglutide is typically appropriate for adults who are overweight or obese (BMI 27 or higher) and who have not achieved lasting results through diet and exercise alone. It is also used in patients with metabolic conditions, insulin resistance, or those who need support jumpstarting significant weight loss.

It is not appropriate for everyone — patients with a history of certain thyroid conditions or pancreatitis may not be candidates. A proper medical evaluation is essential before starting.

What Results Can You Expect?

Clinical trials show patients losing an average of 15 to 20 percent of their body weight over 68 weeks on semaglutide. Results vary based on starting weight, dosage, diet, and activity level — but most patients notice reduced appetite within the first week and meaningful weight loss within the first month.

Ready to Find Out If You Are a Candidate?

At MedTech Management, our medicated weight loss programs are fully supervised by our clinical team. We start with a consultation, review your health history, and build a protocol designed for your specific goals.

Call us at (412) 808-0520 or visit medtechmanagement.com to schedule your free consultation. We serve patients nationwide via telehealth.